A made-in Canada COVID-19 vaccine is said to be showing promising trial results.
The Medicago vaccine is showing showing positive antibody results in its Phase 2 trial, and may even be ready for a final authorization from Health Canada this summer.
While the results are not yet peer-reviewed, Medicago's Executive Vice-President for Scientific and Medical Affairs Nathalie Landry says other vaccines in use showed a similar correlation between the amount of antibodies produced and their effectiveness against the virus.
A Phase Three clinical trial is underway in Canada, the United States and the United Kingdom, with 30,000 participants.
Since a large percentage of Canadians will be fully vaccinated by the end of the summer, Landry says there are talks about testing if Medicago can be mixed and matched with other vaccines as a booster shot.

Oxford OPP Lay Charges After Warrant Execution
Camping Season is Open at Pittock
Application Window Open for Oxford County Grants Program
PJHL Preview - Schmalz Cup Final
Oxford Winds Celebrates 30 Years
Nomination Period Opens for Municipal Election
Theft in Thamesford is Under Investigation
Winning Lotto 6/49 Ticket Sold in Oxford
Thamesford Lions Club Celebrates 65 Years
Yellow Frost Advisory Issued for Oxford
News Poll: Schmalz Cup 2026
Realtors Care Food Drive Returns Next Week
PJHL Playoff Recap - April 29th
Charges Laid After Altercation in Woodstock
New Partnership Protects Land in Oxford
Bomb Threat Unfounded in Woodstock
Big Projects Announced for TVDSB
Tick Season Reminders from Southwestern Public Health
PJHL Playoff Recap - April 28th
Highway Construction Approaching in Burgessville